Selected research
Industry Research
Pharmacokinetics Software Industry Research Report 2026
Market perspective
The global Pharmacokinetics Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacokinetics Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacokinetics Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacokinetics Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacokinetics Software include Certara, Simulations Plus, IntiQuan GmbH, Bayer, Genedata AG, Thermo Scientific, SGS, Pharmaron and Pumas-AI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacokinetics Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacokinetics Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacokinetics Software Market by Company
Certara
Simulations Plus
IntiQuan GmbH
Bayer
Genedata AG
Thermo Scientific
SGS
Pharmaron
Pumas-AI
PharmoGo
Chuangteng Technology
Medixi Biomedical
Pharmacokinetics Software Segment by Type
Compartmental Model
Non-Compartmental Models
Pharmacokinetics Software Segment by Application
Experimental Design
Clinical Pharmacokinetics
Other
Pharmacokinetics Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacokinetics Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Compartmental Model
- Non-Compartmental Models
Applications
- Experimental Design
- Clinical Pharmacokinetics
- Other
Companies covered
- Certara
- Simulations Plus
- IntiQuan GmbH
- Bayer
- Genedata AG
- Thermo Scientific
- SGS
- Pharmaron
- Pumas-AI
- PharmoGo
- Chuangteng Technology
- Medixi Biomedical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacokinetics Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Compartmental Model
- 2.2.3 Non-Compartmental Models
- 2.3 Pharmacokinetics Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Experimental Design
- 2.3.3 Clinical Pharmacokinetics
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Pharmacokinetics Software Breakdown Data by Type
- 3.1 Global Pharmacokinetics Software Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacokinetics Software Forecasted Market Size by Type (2027-2032)
4 Pharmacokinetics Software Breakdown Data by Application
- 4.1 Global Pharmacokinetics Software Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacokinetics Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacokinetics Software Market Perspective (2021-2032)
- 5.2 Global Pharmacokinetics Software Growth Trends by Region
- 5.2.1 Global Pharmacokinetics Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacokinetics Software Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacokinetics Software Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacokinetics Software Market Dynamics
- 5.3.1 Pharmacokinetics Software Industry Trends
- 5.3.2 Pharmacokinetics Software Market Drivers
- 5.3.3 Pharmacokinetics Software Market Challenges
- 5.3.4 Pharmacokinetics Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacokinetics Software Players by Revenue
- 6.1.1 Global Top Pharmacokinetics Software Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacokinetics Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacokinetics Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacokinetics Software Head Office and Area Served
- 6.4 Global Pharmacokinetics Software Players, Product Type & Application
- 6.5 Global Pharmacokinetics Software Manufacturers Established Date
- 6.6 Global Pharmacokinetics Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacokinetics Software Market Size (2021-2032)
- 7.2 North America Pharmacokinetics Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacokinetics Software Market Size by Country (2021-2026)
- 7.4 North America Pharmacokinetics Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacokinetics Software Market Size (2021-2032)
- 8.2 Europe Pharmacokinetics Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacokinetics Software Market Size by Country (2021-2026)
- 8.4 Europe Pharmacokinetics Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacokinetics Software Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacokinetics Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacokinetics Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacokinetics Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacokinetics Software Market Size (2021-2032)
- 10.2 South America Pharmacokinetics Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacokinetics Software Market Size by Country (2021-2026)
- 10.4 South America Pharmacokinetics Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacokinetics Software Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacokinetics Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacokinetics Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacokinetics Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Certara
- 12.1.1 Certara Company Information
- 12.1.2 Certara Business Overview
- 12.1.3 Certara Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.1.4 Certara Pharmacokinetics Software Product Portfolio
- 12.1.5 Certara Recent Developments
- 12.2 Simulations Plus
- 12.2.1 Simulations Plus Company Information
- 12.2.2 Simulations Plus Business Overview
- 12.2.3 Simulations Plus Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.2.4 Simulations Plus Pharmacokinetics Software Product Portfolio
- 12.2.5 Simulations Plus Recent Developments
- 12.3 IntiQuan GmbH
- 12.3.1 IntiQuan GmbH Company Information
- 12.3.2 IntiQuan GmbH Business Overview
- 12.3.3 IntiQuan GmbH Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.3.4 IntiQuan GmbH Pharmacokinetics Software Product Portfolio
- 12.3.5 IntiQuan GmbH Recent Developments
- 12.4 Bayer
- 12.4.1 Bayer Company Information
- 12.4.2 Bayer Business Overview
- 12.4.3 Bayer Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.4.4 Bayer Pharmacokinetics Software Product Portfolio
- 12.4.5 Bayer Recent Developments
- 12.5 Genedata AG
- 12.5.1 Genedata AG Company Information
- 12.5.2 Genedata AG Business Overview
- 12.5.3 Genedata AG Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.5.4 Genedata AG Pharmacokinetics Software Product Portfolio
- 12.5.5 Genedata AG Recent Developments
- 12.6 Thermo Scientific
- 12.6.1 Thermo Scientific Company Information
- 12.6.2 Thermo Scientific Business Overview
- 12.6.3 Thermo Scientific Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.6.4 Thermo Scientific Pharmacokinetics Software Product Portfolio
- 12.6.5 Thermo Scientific Recent Developments
- 12.7 SGS
- 12.7.1 SGS Company Information
- 12.7.2 SGS Business Overview
- 12.7.3 SGS Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.7.4 SGS Pharmacokinetics Software Product Portfolio
- 12.7.5 SGS Recent Developments
- 12.8 Pharmaron
- 12.8.1 Pharmaron Company Information
- 12.8.2 Pharmaron Business Overview
- 12.8.3 Pharmaron Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.8.4 Pharmaron Pharmacokinetics Software Product Portfolio
- 12.8.5 Pharmaron Recent Developments
- 12.9 Pumas-AI
- 12.9.1 Pumas-AI Company Information
- 12.9.2 Pumas-AI Business Overview
- 12.9.3 Pumas-AI Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.9.4 Pumas-AI Pharmacokinetics Software Product Portfolio
- 12.9.5 Pumas-AI Recent Developments
- 12.10 PharmoGo
- 12.10.1 PharmoGo Company Information
- 12.10.2 PharmoGo Business Overview
- 12.10.3 PharmoGo Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.10.4 PharmoGo Pharmacokinetics Software Product Portfolio
- 12.10.5 PharmoGo Recent Developments
- 12.11 Chuangteng Technology
- 12.11.1 Chuangteng Technology Company Information
- 12.11.2 Chuangteng Technology Business Overview
- 12.11.3 Chuangteng Technology Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.11.4 Chuangteng Technology Pharmacokinetics Software Product Portfolio
- 12.11.5 Chuangteng Technology Recent Developments
- 12.12 Medixi Biomedical
- 12.12.1 Medixi Biomedical Company Information
- 12.12.2 Medixi Biomedical Business Overview
- 12.12.3 Medixi Biomedical Revenue in Pharmacokinetics Software Business (2021-2026)
- 12.12.4 Medixi Biomedical Pharmacokinetics Software Product Portfolio
- 12.12.5 Medixi Biomedical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst